The association between fibrotic diseases and treatment-resistant hypertension in England - Takeaways - MDSpire

The association between fibrotic diseases and treatment-resistant hypertension in England

  • By

  • Georgie M Massen

  • Philip W Stone

  • R Gisli Jenkins

  • Richard J Allen

  • Louise V Wain

  • Iain Stewart

  • Upasana Tayal

  • Jennifer K Quint

  • on behalf of the DEMISTIFI consortium

  • February 13, 2025

  • 0 min

Share

  • 1

    Fibrotic conditions are more prevalent in individuals with treatment-resistant hypertension compared to those with managed hypertension.

  • 2

    In a cohort of 1,340,495 people with hypertension, 16.50% had treatment-resistant hypertension.

  • 3

    Treatment-resistant hypertension is significantly associated with various fibrotic conditions, including cardiomyopathy and liver fibrosis.

  • 4

    The study utilized the Clinical Practice Research Datalink to analyze hypertension control and fibrotic condition associations.

  • 5

    Further research is needed to explore the shared mechanisms between treatment-resistant hypertension and fibrotic conditions.

Original Source(s)

The association between fibrotic diseases and treatment-resistant hypertension in England

  • by Georgie M Massen, Philip W Stone, R Gisli Jenkins, Richard J Allen, Louise V Wain, Iain Stewart, Upasana Tayal, Jennifer K Quint, on behalf of the DEMISTIFI consortium

  • February 13, 2025

Related Content

Vascular endothelial integration of multiple biophysical stimuli

Nationwide prospective cohort study in China: the impact of cumulative modified cardiometabolic index on cardiovascular disease incidence

Case Report: A case of acute anterior wall myocardial infarction caused by stent fracture in the left anterior descending artery